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The Nocardia genus, belonging to the order
Actinomycetales, is a group of gram-positive sapro-
phytic bacteria that are found ubiquitously in the
environment. In 2005, Nocardia takedensis was
isolated from moat sediment and sludge around the
Takeda shrine in Japan and reported as a novel
species.1,2 This species shows highest sequence
similarity to Nocardia beijingensis (98.1%-98.3%),
Nocardia brasiliensis (97.9%-98.0%), and Nocardia
tenerifensis (97.9%-97.9%) based on 16S rRNA
sequencing.1 We describe a case of cutaneous
nocardiosis caused by N takedensis, which, to our
knowledge, is the first report of an infection caused
by this species in the United States.
CASE REPORT
A 68-year-old-woman with a history of follicular
lymphoma and myelodysplastic syndrome after
allogeneic peripheral blood stem cell transplantation
presented with new lesions on the left arm. The
patient, a resident of suburban New York, reported a
fall on her outdoor deck 3 months prior, which
resulted in an abrasion on the left dorsal hand. Over
the next several weeks, she had noted the develop-
ment of painful lesions ascending the left forearm.
Her oral medications were budesonide, 9 mg,
sirolimus, 0.5 mg, and prednisone, 10 mg by mouth
each daily. She denied any systemic symptoms,
including shortness of breath. On examination, the
patient’s vital signs were within normal limits and 3
skin-colored to red, tender papules in a lymphangitic
distribution were identified on the left forearm
(Fig 1). A biopsy was performed for histopathologic
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specimen found dense multinodular pandermal
and subcutaneous neutrophilic infiltrates. Gram
and periodic acideSchiff with diastase stains iden-
tified thin, filamentous rods suspicious for
Actinomycetes species (Fig 2), and Grocott-
Gomori’s methenamine silver stain and repeated
Fite stains were negative. After 6 days, a white, dry
colony grew on chocolate agar and Columbia
nalidixic agar media. Gram stain and modified
Kinyoun stain of the colony showed thin, filamen-
tous, gram-positive, acid-fast negative, beaded
branching bacilli. The isolate was subcultured on a
blood agar slant and sent to Mayo Medical
Laboratories for definitive species identification.
Middlebrook 7H10 agar and blood agar plates
were used to grow the bacterium, which was
then analyzed by matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry. The
obtained mass spectrum was compared with an
internal Mayo database but resulted in no matches.
DNA was subsequently extracted for 16S rRNA gene
sequencing. The obtained isolate sequence of
460 nucleotides was analyzed using the National
Center for Biotechnology Information Basic
Local Alignment Search Tool, which found 99.1%
sequence similarity (4 total mismatches) to N
takedensis.
At the time of the skin biopsy, the patient received
cefuroxime, 500 mg by mouth twice daily (7 days),
followed by amoxicillin/clavulanate, 875 mg by
mouth twice daily (14 days), without improvement.
After N takedensis was identified and systemic
disease excluded, she completed 7 days of sulfa-
methoxazole/trimethoprim, 800/160 mg by mouthCancer Center, 16 E. 60th Street, New York, NY 10022. E-mail:
marchetm@mskcc.org.
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Fig 1. Cutaneous nocardiosis from N takedensis infection.
Clinical image of the left upper extremity shows skin-
colored to red papules in a lymphangitic distribution
(black arrowhead corresponds to site of skin biopsy).
Fig 2. Histopathologic image of the tissue specimen
highlights thin filamentous branching gram-positive rods
(black arrows) and abundant neutrophils. (Gram stain;
original magnification: 3400.)
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worsening renal insufficiency after starting the
drug. Despite the short therapeutic course, the skin
lesions gradually resolved over the ensuing 4 weeks.
DISCUSSION
Nocardiosis typically occurs in immunosup-
pressed patients, although as many as one-third of
patients with nocardiosis are immunocompetent.3
Predisposing risk factors to Nocardia infections
include depressed cell-mediated immunity,
including lymphoma and HIV, hematopoietic stem
cell or solid-organ transplants, and long-term
immunosuppression.3,4 Cutaneous manifestations
of nocardiosis can be classified into primary
cutaneous nocardiosis and disseminated disease.
Primary cutaneous nocardiosis results from direct
inoculation of pathogenic Nocardia present in soil
into the skin. Disseminated disease is more common
and usually occurs in the setting of primary pulmo-
nary infection and underlying immunosuppression.3
Primary cutaneous nocardiosis most frequently pre-
sents as lymphangitic papules or draining abscesses.It typically arises in immunocompetent hosts and
follows an indolent course.3 In the patient presented
herein, we suspect that direct cutaneous inoculation
from her fall was the etiology of her infection.
To identify any published cases of cutaneous
nocardiosis caused by N takedensis, we performed
a PubMed search for articles using the search term
‘‘nocardia takedensis’’ without date, language,
publication, or article type restrictions. This search
yielded 10 articles, which were independently
reviewed by 2 authors (EC and MM). Two cases of
primary cutaneous nocardiosis caused by N take-
densis were identified. The first case was from a
patient in Taiwan who had underlying chronic kid-
ney disease and diabetesmellitus and presentedwith
foot cellulitis. The second case was from a healthy
male in Mexico who presented with actinomyce-
toma.4,5 Both patients were successfully treated with
oral trimethoprim-sulfamethoxazole (TMP-SMX). In
addition, N takedensis has been isolated from the
lungs in a patient from Spain with pulmonary
eosinophilic granuloma and was reported to cause
an unspecified infection in a patient in Japan with
T-cell lymphoma.6,7 No reports of patients infected
with N takedensis in the United States were found.
Clinicians and pathologists should be aware that
the Nocardia genus continues to undergo the
addition of new species; more than 50 species have
been identified to date. The species variability in
general morphologic characteristics and acid fast-
ness, which is caused by differences in cell wall
mycolic acid composition and the type of stain used,
make their identification and species differentiation
challenging.3,6,7 As in the case presented herein,
identification using molecular techniques is often
required for a definitive diagnosis and is important
when considering the optimal antimicrobial
treatment. TMP-SMX is active against most species;
however, clinicians should note that Nocardia
otitidiscaviarum, Nocardia nova, and Nocardia
farcinica have shown notable resistance and that
up to 42% of Nocardia isolates submitted to the
Centers for Disease Control and Prevention for
antimicrobial susceptibility testing between 1995
and 2004 were resistant to TMP-SMX.3,8,9 Other
antimicrobial agents that have been used to treat
Nocardia infections include amikacin, impinem,
meropenem, ceftriaxone, cefotaxime, minocycline,
moxifloxacin, levofloxacin, linezolid, tigecycline,
and amoxicillin-clavulanic acid.3
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